Endothelial cells derived from circulating progenitors as an effective source to functional endothelialization of NaOH-treated poly(ε- caprolactone) films

Journal of Biomedical Materials Research - Part A

Volumn 87, Issue 4, 2008, Pages 964-971

  Serrano, M Concepcion ^a   Pagani, Raffaella ^a   Ameer, Guillermo A ^b   Vallet Regí, Maria ^c   Portolés, M Teresa ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Northwestern University   (United States)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Endothelial cell markers; Endothelial progenitor cell; Nitric oxide; Poly( caprolactone); Tissue engineering

Indexed keywords

ABS RESINS; BIOLOGICAL MATERIALS; BIOMATERIALS; BLOOD VESSEL PROSTHESES; CELL CULTURE; CELLS; CYTOLOGY; DIFFERENTIATION (CALCULUS); ELECTRIC CONDUCTIVITY MEASUREMENT; FUNCTIONAL POLYMERS; GRAFTS; HEART VALVE PROSTHESES; NITRIC OXIDE; OXIDES; SELF ASSEMBLY; TISSUE ENGINEERING;

CAPROLACTONE; CELL CYCLES; CIRCULATING PROGENITOR CELLS; DIFFERENTIATION PROCESSES; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIALIZATION; GRAFT FAILURES; IMMUNOLABELING; MITOCHONDRIAL FUNCTIONS; SYNTHASE; SYNTHETIC VASCULAR GRAFTS; THROMBOGENICITY; VASCULAR GRAFTS; VASCULAR TISSUE ENGINEERINGS; VON WILLEBRAND FACTORS;

ENDOTHELIAL CELLS;

CD31 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; POLYCAPROLACTONE; SODIUM HYDROXIDE; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTIBODY LABELING; ANTIGEN EXPRESSION; ARTICLE; BIOFILM; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; MITOCHONDRION; NONHUMAN; PROTEIN EXPRESSION; STEM CELL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; MATERIALS TESTING; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; POLYESTERS; SODIUM HYDROXIDE; STEM CELLS; SWINE; TISSUE ENGINEERING;

EID: 56749096589     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31728     Document Type: Article

References (49)

1. Stansby G, Berwanger C, Shukla N, Hamilton G. Endothelial cell seeding of vascular grafts: status and prospects. Cardiovasc Surg 1994;2:543-548.
2. Callow AD. Current status of vascular grafts. Surg Clin North Am 1982;62:501-513.
3. Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery 1978;84:498-504.
4. Eickhoff JH, Broome A, Ericsson BF, Buchardt Hansen HJ, Kordtm KF, Mouritzen C, Kvernebo K, Norgren L, Rostad H, Trippestad A. Four years results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. J Vas Surg 1987;6:506-511.
5. Deutsch M, Meinhart J, Vesely M, Fischlein T, Groscurth P, von Oppell U, Zilla P. In vitro endothelialization of expanded polytetrafluoroethylene grafts: A clinical case report after 41 months of implantation. J Vasc Surg 1997;25:757-763.
6. Davie EW. Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost 1995;74:1-6.
7. Gimbrone MA Jr, Bevilacqua MP, Cybulsky MI. Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann NY Acad Sci 1990;598:77-85.
8. Harker LA, Mann KG. Thrombosis and fibrinolysis. In: Fuster V, Verstraete M, editors. Thrombosis in Cardiovascular Disorders. Philadelphia, PA: WB Saunders; 1992:1-16.
9. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987;235:1348-1352.
10. Hanson SR, Griffin JH, Harker LA, Kelly AB, Esmon CT, Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest 1993;92:2003-2012.
11. Weksler BB, Marcus AJ, Jaffe EA. Synthesis of prostaglandin I-2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci USA 1977;74:3922-3926.
12. Moncada S. Prostacyclin and arterial wall biology. Arteriosclerosis 1982;2:193-207.
13. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9269.
14. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
15. De Graaf JC, Banga JD, Moncada S, Palmer RMJ, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992;85:2284-2290.
16. Levin EG. Latent tissue plasminogen activator produced by human endothelial cells in culture: Evidence for an enzyme-inhibitor complex. Proc Natl Acad Sci USA 1983;80:6804-6808.
17. Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, Bennett WF, Yelverton E, Seeburg PH, Heyneker HL, Goeddel DV. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983;301:214-221.
18. Dichek D, Quertermous T. Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells. Blood 1989;74:222-228.
19. Heyligers JMM, Arts CHP, Verhagen HJM, de Groot PhG, Moll FL. Improving small-diameter vascular grafts: From the application of an endothelial cell lining to the construction of a tissue-engineered blood vessel. Ann Vasc Surg 2005;19:1-9.
20. Walenta K, Friedrich EB, Sehnert F, Werner N, Nickenig G. In vitro differentiation characteristics of cultured human mononuclear cells-implications for endothelial progenitor cell biology. Biochem Biophys Res Commun 2005;333:476-482.
21. Assmus B, Schachinger V, Teupe C, Britten R, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Circulation 2002;106:3009-3017.
22. Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM, Dimmeler S. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003;107:1024-1032.
23. Shirota T, He H, Yasui H, Matsuda T. Human endothelial progenitor cell-seeded hybrid graft: Proliferative and antothrombogenic potnetials in vitro and fabrication processing. Tissue Eng 2003;9:127-136.
24. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-966.
25. Yamamoto K, Takahashi T, Asahara T, Ohura N, Sokabe T, Kamiya A, Ando J. Proliferation, differentation, and tube formation by endothelial progenitor cells in response to shear stress. J Appl Physiol 2003;95:2081-2088.
26. Riha GM, Lin PH, Lumsden AB, Yao Q, Chen C. Application of stem cells for vascular tissue engineering. Tissue Eng 2005;11:1535-1552.
27. Wu X, Rabkin-Aikawa E, Guleserian KJ, Perry TE, Masuda Y, Sutherland FWH, Schoen FJ, Mayer JE, Bischoff J. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Ohysiol Heart Circ Physiol 2004;287:H480-H487.
28. Hristov M, Erl W, Weber PC. Endothelial progenitor cells. Isolation and characterization. Trends Cardiovasc Med 2003;13:201-206.
29. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today 1994;15:490-495.
30. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31. CD34, von Willebrand factor, and Fli-1 in normal tissues. J Histochem Cytochem 2005;54:385-395.
31. Solomonson LP, Flam BR, Pendleton LC, Goodwin BL, Eichler DC. The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells. J Exp Biol 2003;206:2083-2087.
32. Serrano MC, Pagani R, Vallet-Regí M, Peña J, Rámila A, Izquierdo I, Portolés MT. In vitro biocompatibility assessment of poly(ε-caprolactone) films using L929 mouse fibroblasts. Biomaterials 2004;25:5603-5611.
33. Serrano MC, Portolés MT, Vallet-Regí M, Izquierdo I, Galletti L, Comas JV, Pagani R. Vascular endothelial and smooth muscle cell culture on NaOH-treated poly(ε-caprolactone) films: A preliminary study for vascular graft development. Macromol Biosci 2005;5:415-423.
34. Khang G, Choee J-H, Rhee JM, Lee HB. Interaction of different types of cells on physiochemical treated poly(L-lactide-co-glycolide) surfaces. J Appl Polym Sci. 2002;85:1253-1262.
35. Perego G, Preda P, Pasquinelli G, Curti T, Freyrie A, Cenni E. Functionalization of poly-L-lactic-co-ε-caprolactone: Effects of surface modification on endothelial cell proliferation and hemocompatibility. J Biomater Sci Polym Ed 2003;14:1057-1075.
36. Allen J, Khan S, Concepción Serrano M, Ameer G. Characterization of porcine circulating progenitor cells: Towards a functional endothelium. Tissue Engineering. In press (DOI: 10.1089/TEN.2007.0265).
37. Donnelly R, Yeung JMC. Therapeutic angiogenesis: A step forward in intermittent claudication. Lancet 2002;359:2048-2050.
38. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
39. Nakatsubo N, Kojima H, Kikuchi K, Nagoshi H, Hirata Y, Maeda D, Imai Y, Irimura T, Pagano T. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: Diaminofluoresceins. FEBS Lett 1998;427:263-266.
40. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 2001;26:23-25.
41. Michiels C. Endothelial cell functions. J Cell Physiol 2003;196:430-443.
42. Khor HL, Ng KW, Schantz JT, Phan T-T, Lim TC, Teoh SH, Hutmacher DW. Poly(ε-caprolactone) films as a potential substrate for tissue engineering an epidermal equivalent. Mater Sci Eng C 2002;20:71-75.
43. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228.
44. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000;105:1527-1536.
45. Serrano MC, Pagani R, Manzano M, Comas JV, Portolés MT. Mitochondrial membrane potential and reactive oxygen species content of endothelial and smooth muscle cells cultured on poly(ε-caprolactone) films. Biomaterials 2006;27:4706-4714.
46. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 1985;54:1015-1069.
47. Serrano MC, Pagani R, Peña J, Portolés MT. Transitory oxidative stress in L929 fibroblasts cultured on poly(ε-caprolactone) films. Biomaterials 2005;26:5827-5834.
48. Zhang H, Annich GM, Miskulin J, Osterholzer K, Merz SI, Bartlett RH, Meyerhoff ME. Nitric oxide releasing silicone rubbers with improved blood compatibility: Preparation, characterization, and in vivo evaluation. Biomaterials 2002;23:1485-1494.
49. Genové E, Shen C, Zhang S, Semino CE. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials 2005;26:3341-3351.